First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer

Auteurs

C. Massard, A. Azaro, J.-C. Soria, U. Lassen, C. Le Tourneau, D. Sarker, C. Smith, U. Ohnmacht, G. Oakley, B.K.R. Patel, E.S.M. Yuen, K.A. Benhadji, J. Rodon